(Q34554455)

English

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

M Tanner

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

T T Junttila

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

A I Kapanen

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

S Tommola

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Y Soini

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

H Helin

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

J Salo

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

H Joensuu

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

E Sihvo

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

J Isola

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 February 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Annals of Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

273-278

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

Targeting HER2 in other tumor types

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

Untangling the ErbB signalling network

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

The epidemiology of oesophageal adenocarcinoma: has the cancer of gastric cardia an influence on the rising incidence of oesophageal adenocarcinoma?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

The HER-2/neu oncogene in tumors of the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage, and Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

Prognostic value of Laurén classification and c-erbB-2 oncogene overexpression in adenocarcinoma of the esophagus and gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

Mutations of the human E-cadherin (CDH1) gene.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

Analysis of 154 actual five-year survivors of gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI064

21 January 2018

Identifiers

10.1093/ANNONC/MDI064

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15668283%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34554455&oldid=1636955395"